Insights
Gain perspectives from experts on various policy issues and therapeutic areas through our Insights series that engages multiple managed care stakeholders in video interviews.
All Insights Understanding the Subpopulations of Pulmonary Hypertension Emerging Therapies for Interstitial Lung Disease Migraine Management: The Business Case Management of Diabetic Retinopathy Management of Advanced Fibrosis due to Non-Alcoholic SteotoHepatitis Emerging Agents for Basal Cell Carcinoma and Cutaneous Squamous-Cell Carcinoma Biologics for the Treatment of Adolescent Atopic Dermatitis Understanding Multiple Sclerosis and the Treatment Advances Treatment for Patients With Thromboembolic Complications Non–Small Cell Lung Cancer Clinical Care Emerging Agents for Myelofibrosis Understanding Axial Spondyloarthritis Patient Selection and Safety With TNF Inhibitors Advances in the Treatment of Hyperhidrosis Current Treatment Regimens for Multiple Myeloma Antiangiogenic Therapy: Appropriate Therapeutic Options and Sequencing in NSCLC Personalized Selection of Upfront Therapy in CLL PARP Inhibitors in the Management of Ovarian Cancer Transitions of Care Challenges in Cardiology Defining the Value of Innovation in Oncology New Standards of Care in the Management of Prostate Cancer Assessing the Clinical Utility of Companion Diagnostics Innovation and Role of Alternative Markers of Efficacy Innovative Payment Models in Oncology The Clinical and Reimbursement Landscape of Immuno-Oncology Use of Oral Oncolytics In Palliative Care The Evolution and Clinical Impact of Diagnostic Testing Updates in the Management of Type 2 Diabetes Mellitus and Comorbid
Dyslipidemia Current Clinical Landscape and Managed Care Approach in Multiple Myeloma Updates in the Treatment of Chronic Lymphocytic Leukemia: Implications for Managed Care Updates in the Treatment of Pulmonary Arterial Hypertension Clinical Progress and Coverage Policies in Immuno-Oncology Use of Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation Perspectives in the Management of Non-Small Cell Lung Cancer
May 26, 2020 –
A detailed overview of the complex nature of chronic thromboembolic pulmonary hypertension and associated comorbidity.
May 26, 2020 –
Experts review the challenging nature of portopulmonary hypertension and the appropriate treatment regimens used in this setting.
May 19, 2020 –
Shared insight on portopulmonary hypertension, with deference to risk factors and comorbidities.
May 19, 2020 –
Patient factors that influence the management of connective tissue disease–associated pulmonary arterial hypertension.
May 12, 2020 –
Optimal treatment strategies in the setting of connective tissue disease–associated pulmonary arterial hypertension are reviewed.
May 12, 2020 –
Focusing on CTD-PAH, key opinion leaders discuss how the disease can be identified and relevant impact on quality of life.
May 05, 2020 –
Expert perspective on factors that determine the coverage of agents used to treat PH or PAH.
May 05, 2020 –
Elucidation of the various treatment strategies used in PH and PAH subpopulations: CTEPH, CTD-PAH, and POPH.
April 29, 2020 –
David Hines describes the misconceptions about treatment and prevention for employers and employees. Neil Goldfarb gives final thoughts on migraine management in the workplace.
April 28, 2020 –
Key opinion leaders discuss the respective use of oral, parenteral, and inhaled treatment in PH and PAH.
